Coronavirus Act 2020 (Review of Temporary Provisions) (No. 3)

Maggie Throup Excerpts

Tuesday 19th October 2021 Commons Chamber

[The Parliamentary Under-Secretary of State for Health and Social Care (Maggie Throup)]

It is a pleasure to be closing this debate, and I thank hon. Members from all across the House for their contributions today. It is clear from the speeches we have heard—and, indeed, from the fact that the House can meet at full capacity once again—that we have made so much progress in our fight against covid-19. This is thanks to the perseverance and resolve of the British people, and also to our vaccination programme, which has now given first doses to over 85.9% of the population of the UK over the age of 12. It is this life-saving work that has disrupted the once inevitable link between cases, hospitalisations and deaths, and that has allowed us to start carefully reopening our society and our economy once again.

This battle forced us to take unprecedented steps in pursuit of a lethal virus, and the Coronavirus Act has been a vital weapon in our armoury, but we have said throughout our response that we did not want to keep these powers in place for any longer than we have to and that the House performs an essential role in scrutinising the measures every six months.

In 2020, and shortly after the one-year review, we came before Parliament to remove provisions from the Act that were no longer needed. So far 13 of the non-devolved temporary provisions have already been expired and, as pledged in our autumn and winter plan, we are looking to expire even more of these provisions and will lay regulations very soon to make this happen so that we can continue down the path to normal life.

[Simon Hoare (North Dorset) (Con)]

May I invite my hon. Friend to remind the House and the country that the instincts of the Government sitting behind this Act were benign and in support of public health, not malign and vindictive and trying to erode liberties? These were unprecedented times that required emergency action. Those actions have paid dividends; they were difficult but right. The intention was benign not malign, contrary to what some of our colleagues seem to suggest.

[Maggie Throup]

I thank my hon. Friend for that intervention. The Government were acting in very difficult times and had to take unprecedented measures, as he rightly said.

The Secretary of State explained the provisions in detail in his opening statement, so I will not repeat those that we will be expiring but they include some of the most stringent measures in the Act such as directing the temporary closure of educational institutions, the detention of potentially infectious people, and enabling Ministers to restrict or prohibit gatherings or events. Meanwhile the powers in the Act that we are retaining are those that are critical to our response to the pandemic; after all, as the Opposition spokesman rightly said, this virus has not gone away. We are facing a difficult winter, a time when we have seen from experience that the virus poses a particular threat, so we are keeping in place provisions that are fundamental to our response, for example to make sure the NHS is properly resourced and to support statutory sick pay for those who are self-isolating.

[Bob Stewart]

I rise to repeat the point I made to the hon. Member for Kirkcaldy and Cowdenbeath (Neale Hanvey). It would be very good if the NHSs in all four parts of the kingdom were to get together and ensure that those who have had one vaccination in one part of the kingdom and another in a different part could have a piece of paper that allows them to, for instance, attend a lecture. At the moment, at least one of my constituents is not allowed to go to a lecture because she had one vaccination in England and one in Scotland, and the NHS in Scotland does not recognise the England one and the NHS in England does not recognise the Scottish one. What is going on? It is mad.

[Maggie Throup]

I reassure my right hon. Friend that there are ongoing talks across all the devolved nations and the interoperability of the devices are being looked into; work is under way on that.

[Dr Murrison]

Will my hon. Friend also scrutinise the Bill, as a number of colleagues have mentioned this afternoon, to find those bits that were inserted as expedients but probably need to be refined a little and perhaps given a different statutory basis, such as the certificates in section 19, which for many years have been a nice little money-earner for members of my profession but a burden on the deceased’s estate and which really are not necessary?

[Maggie Throup]

Of course we keep every aspect of the Act under review and will continue to do so.

Members have made a number of compelling points and I would like to address them and respond to some of the questions raised. The shadow spokesman raised the issue of vaccinations and I am pleased to report that 3.6 million booster jabs have been delivered to date over a very short time period. This week sees the launch of a communications campaign on the importance of flu jabs. As my right hon. Friend the Secretary of State announced earlier, the national booking service will open for vaccination bookings for young people shortly and letters will be sent to parents and guardians of children aged 12 to 15 over coming weeks inviting them to book the vaccine online or by calling 119. Jabs will continue to be delivered in schools and if the child has already been invited through their school they do not need to act on their invite unless the parents wish to do so. This is a further option for parents to get their children vaccinated.

In response to my right hon. Friend the Member for Forest of Dean (Mr Harper), on 23 September, the Government laid out their plans for parliamentary scrutiny should there be a need for vaccine certification. The Government recognise the vital importance of parliamentary scrutiny. In addition, there was a call for evidence, which closed on 11 October. I trust that my right hon. Friend was able to contribute to that.

My hon. Friend the Member for Bolton West (Chris Green) raised the issue of care workers. My father was in a care home for seven years. I know from personal experience that care workers become part of the family and play a really important role.

[Mr Harper]

Before my hon. Friend moves on, may I press her a little further? She rightly says that the Government recognise the importance of parliamentary scrutiny. That is welcome, but my question was very specific. The Secretary of State committed to the House’s having to make the decision about vaccine passports, and my question was whether the House would be asked to make that decision in advance and not retrospectively. Can the Minister confirm that the House will be asked to make that decision in advance of any move to implement vaccine passports, and that it will not be asked to approve it retrospectively?

[Maggie Throup]

Covid certification will be brought in under the Public Health (Control of Disease) Act 1984, which, as my right hon. Friend is aware, allows for emergency measures. We will do our utmost to bring forward the vote in Parliament before any enactment of the need for covid certification.

I return to the comments by my hon. Friend the Member for Bolton West. A consultation about making vaccination a condition of deployment in the NHS and wider social care closes on 22 October. We will consider all the responses in due course.

[Chris Green]

Does my hon. Friend share my constituents’ perplexity and confusion that the Government think it is suitable to have compulsory vaccination in care home settings—that has been their intention for many weeks—yet they are still confused or undecided as to whether that is equally relevant in the NHS? Carers are going from care settings into the NHS at the moment.

[Maggie Throup]

I reiterate that we are consulting at the moment for the NHS and other social care settings, and we are not moving the dates that we have already set for vaccination as a condition of deployment in care homes.

The hon. Members for Brent Central (Dawn Butler) and for Twickenham (Munira Wilson), my right hon. Friend the Member for Haltemprice and Howden (Mr Davis) and my hon. Friend the Member for Wycombe (Mr Baker) raised the issue of unlawful convictions. I reassure them that since April 2020, the Crown Prosecution Service has reviewed all prosecutions under the Coronavirus Act, and it continues to do so. As such, the issue is primarily administrative, rather than one of the wrongful use of powers provided by the Act. That policy of review by the CPS has provided an effective safeguard. All incorrect charges made under the Act and reviewed by the CPS have been overturned, and updated guidance has been issued to the police.

[Dawn Butler]

I wonder whether the Minister will also consider the fines under the Public Health (Control of Disease) Act and whether there will be an appeal mechanism. Will she push for that, please?

--- Later in debate ---

[Maggie Throup]

I will take the hon. Lady’s comments on board. The progress that has been made with regard to unlawful convictions has been really helpful.

We have come so far in our fight, but we still have a long way to go. This pandemic is not yet over, and the steps we are proposing will give us the support we need to continue our fight against the virus while restoring yet more of our precious freedoms and the important experiences that we really love.

I commend the motion to the House.

[Madam Deputy Speaker (Dame Rosie Winterton)]

The question is Motion No. 4 as on the Order Paper. As many as are of that opinion, say Aye. [Hon. Members: “Aye.”] Of the contrary, No. [Interruption.] Could I have the Noes again?

Coronavirus Test Device Approval Update

Maggie Throup Excerpts

Monday 18th October 2021 Written Statements

[The Parliamentary Under-Secretary of State for Health and Social Care (Maggie Throup)]

The UK is developing one of the most rigorous regulatory regimes in the world for coronavirus tests. The CTDA regulations have set high bars of specificity and sensitivity to ensure only high quality tests are available on the UK market. The CTDA regulations have set high bars of specificity and sensitivity to ensure only high quality tests are available on the UK market.

The Secretary of State and I have been impressed by the number of applications the regulator has received. This is a testament to the willingness of businesses to rise to the public health challenges set by this pandemic. However, some manufacturers have struggled to provide sufficient evidence in time. As things stand, this would mean they would have to be temporarily removed from the market whilst they complete their validation. This would create an unexpected contraction in supply at the start of winter. This could be particularly problematic for testing returning travellers.

In order to protect public health by ensuring availability of tests, the Secretary of State has decided to exercise the power under regulation 39A of the Medical Devices Regulations 2002. He will publish a protocol today listing certain tests that have both passed a public sector validation, and have a pending application awaiting validation, to remain on the market up to 28 February 2022 or until their validation application is determined. This protocol is a short-term, proportionate and targeted measure to minimise a risk of serious harm to public health by ensuring that a supply of tests most likely to be of high quality, having passed validation as part of DHSC procurement or other public sector process, remain on the market on an interim basis.

Copies of the protocol will also be deposited in the Libraries of both Houses and it will be published on the gov.uk website.

[HCWS324]

Covid-19: Vaccination of Children

Maggie Throup Excerpts

Tuesday 21st September 2021 Westminster Hall

[The Parliamentary Under-Secretary of State for Health and Social Care (Maggie Throup)]

I thank my hon. Friend the Member for Penistone and Stocksbridge (Miriam Cates) for securing this important and timely debate on the vaccination of 12 to 15-year-olds against covid-19. She quite rightly highlighted the importance of vaccine roll-outs and the programmes that we have had for many decades, and I thank her for that.

Before I respond to the various questions and points raised by hon. Members, I pay tribute to my predecessor, my right hon. Friend the Member for Stratford-on-Avon (Nadhim Zahawi), for his efforts in successfully delivering the vaccine programme, with more than 93 million doses administered in the UK and more than four fifths of adults receiving the protection of two jabs. I aim to build on that very solid foundation in my new role.

I also put on record that I am very grateful to everyone who has played a crucial role in the success of the vaccine roll-out, from our brilliant scientists, clinical trial participants, the armed forces, NHS England, frontline healthcare workers, vaccine volunteers and local and central Government. Our jabs have already prevented more than 112,000 deaths, 230,000 hospitalisations and more than 24 million infections. They have built a vast wall of defence for the British people.

Earlier this year, our medicines regulator, the MHRA, approved the Pfizer and Moderna vaccines for 12 to 17-year-olds. The MHRA authorisation decision confirmed that vaccines are safe and effective for this age group. On this decision, the Joint Committee on Vaccination and Immunisation recommended vaccination for 12 to 15-year-olds with serious underlying health conditions. In August, the committee advised an initial dose of the vaccine for all healthy remaining 16 and 17-year-olds. The JCVI then looked at whether we should extend our offer of vaccination to all 12 to 15-year-olds. It concluded that there are health benefits to vaccinating this cohort, although they are finely balanced.

However, the JCVI’s remit does not include the wider impacts of vaccinations, such as the benefits for children in education or the mental health benefits that come from people knowing that they are protected from this deadly virus. The JCVI therefore advised that the Government might wish to seek further views on those wider impacts from the UK’s chief medical officers across all four nations. The Secretary of State and the Health Ministers from the devolved nations accepted that advice. Our CMOs consulted clinical experts and public health professionals from across the United Kingdom, such as those from the Royal College of Paediatrics and Child Health. I trust that that reassures my hon. Friend the Member for Northampton South (Andrew Lewer), who raised concerns about professional advice.

We received advice from the four chief medical officers, and it was made publicly available and deposited in the Library for Members to read in full. The unanimous recommendation of the UK’s chief medical officers is to offer all remaining 12 to 15-year-olds a first dose of the Pfizer vaccine, with further JCVI guidance needed before any decision on a second dose. The CMOs have been clear that they make this recommendation based on the benefits to children alone, not on the benefits to adults or wider society.

I can confirm that the Government accepted this recommendation. We are now moving forward with the same sense of urgency that we have had at every point in our vaccination programme. I am delighted that a 14-year-old in Essex yesterday became one of the first children in the country to receive a covid-19 vaccination in school.

[Chris Green]

Will my hon. Friend set out exactly why it is recommended for adults to have two doses and perhaps later a booster dose of the vaccine, but for children it is a single dose?

[Maggie Throup]

I thank my hon. Friend for his intervention, and I reassure him that the evidence is continually being observed and recorded. Further advice will be taken on whether a second dose is needed for the younger age range. Evidence is being gathered all the time.

I appreciate that there are questions about how the process of consent will work in circumstances where parents and children disagree. I reassure my hon. Friend the Member for St Ives (Derek Thomas) that, as with all vaccinations for children, parental consent will be sought. The consent process is being handled by each school in its usual way and provides sufficiently for parents to give their consent. Children aged 12 to 15 will also be provided with information, usually in the form of a leaflet for their own use and to share and discuss with parents prior to the date on which the immunisation is scheduled.

Parental, guardian or carer consent will be sought by the school age immunisation service prior to vaccination, in line with other school vaccination programmes. That service will carry out the vaccinations, and I trust that that reassures my hon. Friend the Member for Northampton South. The school age vaccination service has vast experience of dealing with a number of other vaccine roll-outs in secondary schools, such as the human papillomavirus vaccine and the three-in-one teenage booster that protects against tetanus, diphtheria and polio. The clinicians who work on these roll-outs are very well equipped and very well versed in dealing with vaccines in schools.

In their advice, the four CMOs have said it is essential that children and young people aged 12 to 15, and their parents, are supported in whatever decisions they take, and that they are not stigmatised for accepting or not accepting the vaccination offer. Individual choice should be respected. It is the opportunity to be vaccinated that is on offer, in a fair and equitable manner.

To those who remain undecided, I say this. The MHRA is the best medical regulator in the world. It has rigorously reviewed the safety of our vaccines, and it only authorises those that it concludes are safe. Vaccines for children and young people are no exception. We continue to have a comprehensive safety surveillance strategy in place across all age groups to monitor the safety of all covid-19 vaccines that are approved for use in the UK.

I will now address some of the interventions and questions from hon. Members. My hon. Friend the Member for Penistone and Stocksbridge asked a number of questions. I reiterate that the CMOs sought advice from experts in the field; it was not just the information they had themselves. It is only right that, based on that advice, 12 to 15-year-olds are able to take up the offer of the vaccine in a fair and equitable manner.

My hon. Friend asked about disruption to education from the programme. NHS England already has plans in place for the mop-up programme, which is not likely to be on school sites, to minimise disruption to education and the rest of the immunisation programme.

[Miriam Cates]

I very much appreciate the point and the reassurance the Minister is giving, but even the CMOs acknowledge that the vaccine programme in and of itself is not going to end disruption to schools. Whether people choose to have this vaccine or not—which absolutely should be a free decision, as the Minister says—what is more important is the policy making around having consistent rules in schools, as the hon. Member for Strangford (Jim Shannon) said, but also ending mass asymptomatic testing, which is picking up cases that it does not need to pick up and is itself causing disruption. How will the disruption to schools end, even if vaccination does go ahead and cover a wide population?

[Maggie Throup]

I thank my hon. Friend for that intervention. It is important that we do whatever we can—use whatever we have in our toolbox—to make sure that children are able to continue with their education, and vaccination is one part of that. I know my hon. Friend is passionate, as am I, about making sure that children get a full education, and that the pandemic does not affect their futures. My hon. Friend raised several other questions and, if she will allow me, I will write to her in response to any I do not answer in my speech.

My hon. Friend the Member for Lincoln (Karl MᶜCartney) raised questions about guidance for schools on the vaccination programme. How the programme will work has been set out very clearly, including in the formation of the consent process, most recently updated on 17 September 2021. I would like to reassure my hon. Friend, who highlighted the three words “do no harm”, that robust monitoring arrangements are in place for the vaccination of 12 to 15-year-olds, and that further data will be available shortly.

I join the hon. Member for Leicester West (Liz Kendall) in absolutely condemning the threats and intimidation of headteachers, school staff and anybody who enters school premises. That is a big issue, and my advice is that headteachers who have received such intimidation should rapidly contact the school age immunisation service, which is well versed in addressing it. They should not be afraid to speak to the police and the local authority too. I assure her that that issue is extremely high on my priority list, which, as she can imagine, is getting longer.

It is important that we remember that our teenagers have shown great public spirit at every point during the pandemic, and I thank them for that. They have stuck to the rules so that lives can be saved and people kept safe, and they have been some of the most enthusiastic proponents of vaccines.

[Chris Green]

Certain drug companies are now looking to get approval for vaccinations for five-year-olds. Does the Minister rule that in or out in the United Kingdom?

[Maggie Throup]

My focus at the moment is on ensuring the effective roll-out of the programme for 12 to 15-year-olds. We must ensure that the booster programme is rolled out effectively, and encourage the last few people who have not yet had the vaccine—I think it is about 5 million—to take up that offer.

[Karl MᶜCartney]

Will the Minister give way?

[Maggie Throup]

I will give way one final time.

[Karl MᶜCartney]

I am conscious there are a few minutes left in this debate, so I want to refer quickly to three more issues. First, the Minister may have noticed that the first speech in support of the Government’s position came from an Opposition Member, who claimed to be speaking on behalf of all Opposition MPs, although there is only one here.

Secondly, a point was made about the seat of the hon. Member for Leicester West (Liz Kendall) and the number of young people who have, I believe, covid, although she did not give the actual number. However, if school children were not tested over the summer, surely they are now being tested in school and the incidence of those with covid will be rising. Therefore, I am being very gracious to both Front Benchers—

[Karl MᶜCartney]

It is, but I am coming to the end of my comments, Dame Angela. I am conscious of that. When I was growing up, there was a very famous pop song called “Don’t Believe the Hype”. Surely that is something we should all be taking notice of.

[Maggie Throup]

I will take my hon. Friend’s comments on board. More than half of 16 and 17-year-olds across the United Kingdom have had the jab, despite most having become eligible only last month, which shows young people’s enthusiasm to come forward and play their part.

At every point in our vaccination programme, we have been guided by the best clinical advice. The advice that we received from the four chief medical officers last week sets out their view that all 12 to 15-year-olds will benefit from vaccination against covid-19. We will follow that advice and continue that vital path to ensure we keep more and more people in this country safe.

Fortification of Flour: Folic Acid

Maggie Throup Excerpts

Tuesday 21st September 2021 Written Statements

[The Parliamentary Under-Secretary of State for Health and Social Care (Maggie Throup)]

I am today announcing the Government’s decision to introduce mandatory fortification of flour with folic acid to help prevent neural tube defects in foetuses. The Government initiated a consultation in 2019 on the issue of folic acid fortification. Our response is published today and confirms that we will proceed with fortification of non-wholemeal wheat flour, which is the most used type. This was the “baseline” option in the consultation and accompanying impact assessment.

Neural tube defects are birth defects of the brain, spine, or spinal cord. They happen in the first few weeks of pregnancy, often before a woman even knows that she is pregnant. The two most common neural tube defects are spina bifida and anencephaly. These can be devastating conditions, and the Government are fully aware of the effect these have on the individuals themselves and their families.

There is strong evidence that many neural tube defects can be prevented by increasing women’s intake of folic acid, which is why existing pregnancy advice to women who are trying to conceive or who are likely to become pregnant is to take a daily supplement of 400 micrograms of folic acid until the 12th week of pregnancy.

However, we know that in the UK around half of pregnancies are unplanned. In those which are planned, it has been estimated that only half of all mothers took folic acid supplements or modified their diet to increase folate intake. This has led to calls for mandatory fortification of flour with folic acid, so women can get it from dietary sources other than foods that naturally contain it, and is why we consulted on the proposal.

I am grateful to the many people who took time to respond to the consultation which helped us accurately consider this policy.

I have agreed with the Governments of Scotland, Wales, and Northern Ireland that we intend to implement this change on a UK-wide basis. We will now commence detailed discussions with stakeholders on the precise details of the fortification and labelling requirements, and agree the appropriate lead-in times. In order to minimise impacts on industry, this will be co-ordinated as part of a wider review of The Bread and Flour Regulations 1998 and The Bread and Flour (Northern Ireland) Regulations 1998 being undertaken by DEFRA—alongside the Food Standards Agency in Northern Ireland and Wales, Food Standards Scotland in Scotland, DHSC, and the Scottish and Welsh Governments. Following those discussions, and in co-ordination with the progress of the review of the wider bread and flour regulations, we will consult on the draft legislation to implement this policy, and include a full impact assessment on the mandatory folic acid fortification.

[HCWS296]

Covid-19 Vaccinations

Maggie Throup Excerpts

Monday 20th September 2021 Westminster Hall

[The Parliamentary Under-Secretary of State for Health and Social Care (Maggie Throup)]

Thank you, Ms Ghani.

I am grateful to my hon. Friend the Member for Carshalton and Wallington (Elliot Colburn) for introducing this debate on these important topics, and I commend him for setting out the importance of vaccines in combating so many diseases. When we look at the history of vaccination programmes in previous eras, we realise just what impact they have had on people’s lives.

We know that the covid vaccination programme is the nation’s best line of defence against covid-19. Vaccinated people are far less likely to face severe disease from covid-19, to be admitted to hospital or to die from it. They are also less likely to pass the virus to others. More than 93 million covid-19 vaccinations have already been administered, and the latest estimates from Public Health England indicate that the programme has saved more than 112,300 lives and prevented more than 24 million cases.

As other hon. Members have done, I pay tribute to everyone who has played a crucial role in the success of the vaccine roll-out—our brilliant scientists, clinical trial participants, the armed forces, NHS England, frontline healthcare workers, vaccine volunteers and local and central Government. Their life-saving efforts have helped to maintain the rapid pace of the roll-out across the entire country. I also recognise the brilliant work of the former Minister for vaccines, my right hon. Friend the Member for Stratford-on-Avon (Nadhim Zahawi). I know that I have very big shoes to fill.

The public’s continued willingness to get vaccinated, to test, to self-isolate if they have symptoms and to follow behaviours and actions that mitigate all methods of transmission has played a key role in the lifting of restrictions. Over autumn and winter, the Government will aim to sustain the progress made and prepare the country for future challenges, while ensuring that the national health service does not come under unsustainable pressure.

In my first debate as Minister with responsibility for vaccines, I join the plea of my hon. Friend the Member for Carshalton and Wallington and other hon. Members for those not yet vaccinated to take up their vaccine offer and join the around 89% of the UK who have had at least their first dose. I am sure the whole House will join me in thanking them for playing their part in helping us all to live safely.

We will continue to make vaccines easily available to everybody, to maximise uptake among those who are eligible but to date have not taken up the offer. In England, 11.3% of people ages 16 and older—more than 5.5 million people—remain unvaccinated, which heightens the risk of rising hospitalisations, particularly when prevalence is high. Take-up so far varies by ethnicity, age and deprivation, with some groups recording lower rates of vaccine uptake than others.

Building on lessons learned through phases 1 and 2 of the vaccine roll-out, the Government continue to work closely with the NHS to make it as easy as possible to get a vaccine, including through “Grab a Jab” in England, pop-up vaccine sites across the country and easy-to-use walk-in sites found on the NHS website. Pop-up sites include those at football stadiums and shopping centres, reaching out to the whole community. The Government have partnered with transport providers, such as Uber and FREE NOW to ensure access to vaccine sites is easier than ever before.

The hon. Member for Birmingham, Erdington (Jack Dromey) asked how the Government have reached out to people who are hesitant to take part in the vaccination programme. Despite having been in post for only a matter of days, I reassure him that the Government and the NHS are working closely together to ensure that we reach out and get the extra 5.5 million jabs into the arms that need them, and fill the gap that is in the community. I reassure him that that is one of my key priorities in my role as vaccine Minister.

The last 18 months have shown that the pandemic can change course rapidly and unexpectedly. It remains hard to predict with certainty what will happen. There are a number of variables, including the levels of vaccination, the extent to which immunity wanes over time, how quickly and how widely social contact returns to pre-pandemic levels, which is partly to do with the return to schools and as offices reopen, and whether a new variant emerges that fundamentally changes the Government’s assessment of the risk. That is why the autumn and winter plan sets out our plan B.

Vaccine status certification is part of the Government’s plan B if the data suggests action is required to prevent unsustainable pressure on the NHS. For venues, certification could allow settings that have experienced long periods of closure to remain open, compared to more stringent measures that may severely reduce capacity or cause them to close entirely. The autumn-winter plan committed to publishing further details shortly on the proposed certification regime that would be introduced as part of plan B.

In this scenario, certification would be introduced in a limited number of venues. Communal worship, wedding ceremonies, funerals and other commemorative events and protests would also not fall under the certification regime. Exemptions would continue to apply for those who cannot be vaccinated for medical reasons, those on covid vaccine clinical trials and for under-18s.

The NHS covid pass would continue to certify individuals based on vaccination, testing or natural immunity status, with more than 200 events and venues already introducing voluntary certification and the NHS covid pass as a condition of entry.

Care home staff provide a critical role in supporting the health and wellbeing of some of the most clinically vulnerable to the effects of covid-19 in society, and have maintained their dedication and professionalism through highly challenging conditions. Since the start of the pandemic, the Government have committed over £6 billion to local authorities through non-ringfenced grants to tackle the impact of covid-19 on their services, including adult social care. We continue to be committed to supporting the social care sector.

To prevent individual susceptibility to covid-19, from 11 November it will be a condition of deployment for anyone working or volunteering in Care Quality Commission regulated care homes that provide accommodation for persons who require nursing and personal care to be fully vaccinated. Thanks to the incredible efforts of people across the sector, over 1.2 million social care workers in England have now been vaccinated. This is a fantastic achievement and an important step for staff to protect themselves, their loved ones and the people they care for from becoming seriously ill or dying from covid-19.

[Graham Stringer]

Can the Minister answer the question that her predecessor failed to answer on the Floor of the House on Second Reading of the Bill? Everybody agrees that it would be a good idea if all care workers were vaccinated, but why will it be effective to force reluctant care workers to either have it or lose their employment, when other people entering care homes—hairdressers, musicians and entertainers and such—would not be forced to? How is that an effective policy?

[Maggie Throup]

I thank the hon. Gentleman for the question. If he will excuse me, I have obviously been in post a short time. As I am led to believe, it is people who regularly go into care homes that will need this. It is not just restricted to the actual carers. If anybody needs to go into a care home in an emergency situation, that is a different scenario. If I may, however, I will clarify that after the debate.

Vaccine uptake nationally in the care home workforce is high, at 85.6% for first doses. This is in line with vaccine uptake in the general population. There is, however, significant variation at a regional, local and individual care home level. Vaccine requirements are designed to level up uptake in the care home workforce. While the majority of care home workers have been vaccinated, the latest published data as of 12 September highlighted that only 81.3% of older adult care homes in England were meeting the SAGE advice that 80% uptake of first doses among staff is the minimum needed to reduce the risk of outbreaks in these high-risk care settings.

While residents in care homes are some of the most at risk from covid-19, the responses to this initial consultation on care homes made a clear case for extending this policy to other settings where vulnerable people receive care and treatments. The Government are therefore seeking views on whether to extend vaccination requirements to other frontline health and care workers—those with face-to-face contact with patients and clients through the delivery of services, as part of a CQC regulated activity. Recent research has shown that people infected with both flu and covid-19 are more than twice as likely to die as someone with covid-19 alone and nearly six times more likely than those with neither flu nor covid-19, so vaccination requirements for both flu and covid-19 are being considered.

I trust that the debate will have helped to dispel some of the myths that hon. Members have raised about vaccinations, and will really reach out to the public to ask them, as colleagues have done, to go and get vaccinated to protect themselves and others. To conclude, I reassure the House that we are doing everything we can to widen and deepen our wall of defence that the vaccine provides. The ask of our NHS colleagues is challenging and complex, yet they have risen to this challenge and do it every day. Once again, I thank them for their dedication.

[Ms Nusrat Ghani (in the Chair)]

Thank you, Minister, and well done on your first time speaking from the Front Bench.

Healthcare (International Arrangements) Bill (First sitting)

Maggie Throup Excerpts

Committee Debate: 1st sitting: House of Commons
Tuesday 27th November 2018 Public Bill Committees

[Julie Cooper]

Q Thank you. Mr Jethwa, would you like to comment on the same issue?

Raj Jethwa: It is important that an agreement can allow a seamless operation, but there are some well-established ethical principles and safeguards in relation to this. First, it has to be relevant data and it has to be accessed on a need-to-know basis, and only when it is in line with patients’ expectations. Data sharing has to be transparent. We would be absolutely concerned that any safeguards meet those criteria and principles. I do not think the details in the Bill make that clear at the moment. We would like to see more clarity and detail about that in future.

[Maggie Throup (Erewash) (Con)]

Q Mr Jethwa, when you look at the current regulations, do you think the powers in the proposed legislation are proportionate?

Raj Jethwa: We would like to see much more emphasis on scrutiny of all the discussions in the arrangements going forward. There are some negative procedures—I think that is the term. Given the weight of the issue and the number of people that could be affected by it—I have mentioned the 190,000 UK pensioners who live abroad at the moment, but there are close to 3 million people from the European Union who access healthcare in this country, and there are many more than that who travel across the European Union at the moment—there probably needs to be greater scrutiny of any arrangements going forward.

[Matt Western (Warwick and Leamington) (Lab)]

Q Mr Henderson, I think you described the existing arrangements as pretty well universal. Could you explain a little more what the gaps are?

Mr Henderson: I am not actually sure I have all the detail. My understanding is that the European health insurance card and such arrangements work for all emergency situations, certainly, and most normal circumstances. I think, and Raj may know better than I, that there are some areas that are not covered particularly, but as I understand it, it is fairly universal. I am not an absolute expert in that, I am afraid.

Raj Jethwa: We can write to the Committee. My opinion is that it is pretty universal. There are probably niche areas that may not be covered. We can look into that and get back to the Committee if that would be helpful.

Junk Food Advertising and Childhood Obesity

Maggie Throup Excerpts

Tuesday 16th January 2018 Westminster Hall

[Maggie Throup (Erewash) (Con)]

I beg to move,

That this House has considered the effect of junk food advertising on obesity in children.

It is a pleasure to serve under your chairmanship, Ms Dorries, for what I think is the first time. I thank colleagues across all parties for supporting my bid for this debate to the Backbench Business Committee, and I thank the Backbench Business Committee for understanding the importance of junk food advertising and its impact on childhood obesity and for granting this debate.

If hon. Members will excuse the pun, the size of the issue is getting bigger. Some 23% of children in reception are overweight or obese, rising to 34% of children in year 6, and the prevalence is higher for boys than girls in both age groups. Over the last 30 years, there has been a substantial increase in average weight in the UK and, at the same time, a decline in the quality of diets. It is predicted that if current trends continue, half of all children will be obese or overweight by 2020, which is just two years away.

Obese children are about five times more likely to remain obese in adulthood, so acting early can protect them from a lifetime of avoidable ill-health and disease. Obesity can lead to a number of serious and potentially life-threatening conditions, such as type 2 diabetes, heart disease and cancer. Recently, cases of type 2 diabetes have been reported in teenagers, although until now it has been recognised as a disease of older age. Obesity costs the national health service an estimated £5.1 billion and the UK economy £27 billion each year, so it is of the utmost economic importance that the obesity epidemic is addressed. I fear that those costs are grossly underestimated.

Obesity is strongly linked to socioeconomic deprivation. Findings from the most recent national child measurement programme show that inequalities in obesity prevalence between the most and least deprived quintiles of children in reception are widening faster than expected. Obesity is also twice as prevalent among children living in the most deprived parts of England than among those in the least, and patterns are similar across Scotland and Wales. That reflects the fact that families from lower socioeconomic backgrounds across the UK have the poorest diets, high in saturated fat and low in fruit, vegetable and fibre consumption.

Research also shows that the poorest UK households are exposed to twice as many television food adverts than the most affluent viewers. That exposure is problematic. Food advertising in the UK disproportionately features unhealthy food items, and young children are especially vulnerable to marketing techniques that promote unhealthy food. The pervasive harms of adverts place untold pressures on the poorest in society. Children with low nutritional knowledge are more likely than those with higher literacy to select unhealthy meals after seeing junk food adverts. Junk food marketing exacerbates health inequalities, especially among very young children and adolescents.

Over the last couple of years, there has been much focus on the impact of sugar on children’s health and the growing problem of obesity. However, we must not lose sight of the role that foods high in fats and salt play in the epidemic of obesity sweeping our nation. I am sure that Jamie Oliver’s visualisation of the amount of sugar in fizzy drinks in teaspoons helped the public to understand the issue, but we need to go further. The salt content of processed food has decreased over the past decade, mainly as a result of successful campaigning, and it is now common to find low-fat alternatives on supermarket shelves, but there is more still to do. As we focus our minds on trying to rid ourselves of those few extra pounds we mysteriously gained over the festive season, it is the right time to focus the Government’s mind on continuing measures to continue to tackle the obesity epidemic.

[Paul Blomfield (Sheffield Central) (Lab)]

I congratulate the hon. Lady on securing this debate, and she is making a powerful contribution about the scale of the crisis. Prevention is clearly more important than cure, but given where we are now, does she acknowledge that we also need to focus on cure? Does she share my concern that too few clinical commissioning groups are commissioning tier 3 services, which can make positive interventions to support seriously obese children?

[Maggie Throup]

I agree completely. We need to consider prevention, cure and treatment. It is a huge problem, and it will not go away unless we tackle every aspect of it. The hon. Gentleman makes a good point.

The debate in Parliament on the impact of junk food, by which I mean food high in fats, salt and sugar, is not new. I talked to somebody just last week who gave me the insight that we have been discussing it for getting on for 15 years—probably more than that, if we backtrack even further—and we still do not have the courage to ban the advertising of products with such a major impact on the health of our nation and our future generations.

Recently, the Select Committee on Health held an inquiry and produced a report, “Childhood obesity—brave and bold action”, followed up in a short report early last year. Both reports contained a strong call for a ban on junk food advertising before the 9 o’clock watershed, yet that was sadly missing from the Government publication “Childhood obesity: a plan for action”, introduced in August 2016.

I am delighted that new rules on advertising were introduced by the Committee of Advertising Practice in July 2017—their impact is still being analysed. The rules banned the advertising in children’s media of food or drink products high in fat, salt or sugar. The restrictions now apply across all non-broadcast media, including print, cinema, online and social media, but that does not solve the problem. In 2015, Public Health England recommended extending current restrictions to apply across the full range of programmes that children are likely to watch, rather than limiting them to children-specific programming. Yes, restrictions apply to advertising high fat, salt and sugar products during prime time, but only when the audience is made up of 20% children or more.

A recent study commissioned by the Obesity Health Alliance found that 59% of food and drink adverts shown during family viewing time would be banned from children’s TV, yet hundreds of thousands of children are exposed to them every week. In the worst-case example, children were bombarded with nine adverts for products high in fat, salt and sugar in one 30-minute period. Adverts for fast food and takeaways appeared more than twice as often as any other type of food and drink advert, while adverts for fruit and vegetables made up just over 1% of food and drink adverts shown during family viewing times. The study also showed that the number of children watching TV peaks between 7 pm and 8 pm, definitely not when children-only programmes are shown.

Although I recognise that advertising restrictions in the UK on high fat, salt or sugar products are among the toughest in the world, we need to be even tougher. The childhood obesity plan published by the Government in August 2016 states that it is only the start of the conversation. This debate aims to help continue that conversation and focus on other measures that the Government can take to stop and reverse the obesity epidemic.

[Mr Gregory Campbell (East Londonderry) (DUP)]

I congratulate the hon. Lady on securing this debate, which is similar to one that I secured six years ago in Westminster Hall. The situation has worsened considerably in that time. Does she agree that the plan that she just elaborated on needs action points from the Government along the lines that she has intimated? We need outcome targets so that the next generation of children will see a significant improvement, rather than the deterioration in the current generation.

[Maggie Throup]

I agree completely, and I thank the hon. Gentleman for that intervention. I was always taught that measures put in place with no targets or goals to meet are meaningless. We need to know where we want to be, and by when.

[Dr Dan Poulter (Central Suffolk and North Ipswich) (Con)]

I congratulate my hon. Friend on securing this debate. I am sure she will agree that the obesity problem is growing and that measures to tackle it have been wholly inadequate. As with smoking, when we know something is harmful, we need a step change in measures to deal with it. An out-and-out ban on advertising—other hon. Members may comment on that—and a consideration of how we could severely restrict how high fat, salt and sugar foods and drinks are sold may be ways to take the strategy forward.

[Maggie Throup]

My hon. Friend is right—his background makes him an expert in the field—that no one measure will solve the problem. The Health Committee has called for “bold and brave action”, but we are a long way from seeing that.

No one measure will successfully tackle childhood or adult obesity. It is more than just sugar—many different aspects of food are causing the obesity epidemic. The soft drinks industry levy will play its part, as will Public Health England’s message, which was well publicised over Christmas and new year, that children should have only two snacks a day. Tackling junk food advertising is an important part of the jigsaw.

[Conor McGinn (St Helens North) (Lab)]

When the sugar tax was introduced, Vimto, which has its headquarters in my constituency, would have avoided it on 60% of its products because they were already sugar free. That figure is now 100% because industry growth has been led by the fact that 70% of demand is for sugar-free drinks. In contrast, £200 million was taken from the public health budget in 2015-16, £85 million was taken in 2016-17, and 3.9% will be taken each year up to 2020. In some respects, the industry and the public are ahead of the Government.

[Maggie Throup]

There has been a step change in the industry. It has realised that if it does not take steps itself, more punitive measures may be imposed. Hopefully, debates such as this one will help the industry and other corporate bodies to take responsibility, which is a good way to address the issue.

It is well recognised that children and young people are particularly vulnerable to junk food advertising. Evidence shows a link between advertising and the types of food that that group prefer to buy and eat. Restrictions to advertising in or around programmes specifically made for children were introduced 10 years ago, but no Government since have made any effort to update the broadcast rules, despite widespread recognition of the health harms of junk food advertising. Anybody watching “Newsnight” last night will have seen that advertisers are finding ways to circumvent the rules, which is not what rules are there for.

By applying broadcast restrictions only to children’s programming, the pattern of TV viewing by children today is not taken into account.

[Louise Haigh (Sheffield, Heeley) (Lab)]

The hon. Lady makes a powerful case about advertising. Evidence suggests that children as young as 18 months old can recognise branded products, so it has a significant and pernicious impact on very young children. Many people may not expect that. Does she agree that the rules need to be extended, not just for broadcast to ensure that they affect family viewing time, but to online advertising as well?

[Maggie Throup]

I completely agree. Some of the new restrictions imposed by the Committee of Advertising Practice in July aimed to do that, so that whatever method a child is viewing by, whether it is gaming or whatever, it is controlled. At a meeting just before Christmas, the committee said that it had still not been able to analyse the impact of the restrictions. Hopefully, in a few months’ time, we will get some feedback as to whether they are working or not—let us hope that they are.

Children are viewing TV—and lots of other media, as the hon. Lady said—in different ways, so we are calling for that to be taken into consideration to ensure that legislation is up to date. The rules are outdated and we urgently need an update to reflect changing viewing patterns.

We could debate whether restrictions on advertising are the responsibility of the Department of Health and Social Care or of the Department for Digital, Culture, Media and Sport, but ultimately we are discussing the health of our future generations. The Department of Health and Social Care should grasp that responsibility and make a difference.

The soft drinks industry levy, which has received a tremendous amount of attention, is a matter for the Treasury, but it appeared in the childhood obesity plan published by the then Department of Health in August 2016. There is no reason why introducing advertising restrictions for the sake of our nation’s health should be deemed to be under the DCMS remit.

The Minister indicated to me that it was too early to have this debate as he may not be able to give any concrete answers, but it is never too early to have a debate on an issue that affects our children’s health. “Childhood obesity: a plan for action” states that it is just the “start of a conversation”. It would be wrong of us, as parliamentarians, not to take every opportunity to continue that conversation. I hope that this debate influences the next stages of the measures to tackle childhood and adult obesity.

We have passed the stage of assuming that the implementation of further restrictions to the advertising of food and drinks high in fats, salt and sugar is part of a nanny state. There is now consensus across the House that responsibility and duty of care needs to be shown to our children and young people through bold and brave actions that will have an impact not only on future generations but on people today.

Before I finish, I have two more thoughts to throw into the mix. First, we should be mindful that there must be an element of personal and parental responsibility. Secondly, it is not a coincidence of scheduling that these adverts run alongside some of our biggest TV shows, such as the “The X Factor”, “Britain’s Got Talent”, “I’m a Celebrity”, “Hollyoaks” and “The Simpsons”. If we are to truly effect change, we need some of that star magic, as Jamie Oliver demonstrated.

The power of celebrity cannot be underestimated. With that in mind, I call on household names such as Simon Cowell, Ant and Dec, Dermot O’Leary and Amanda Holden to take some corporate responsibility, stand up to broadcasters and say that they will no longer be used as a hook to sell harmful junk food to our children and theirs.

[Dr Poulter]

My hon. Friend has made excellent points throughout her speech. Certain sports teams and events are sponsored by junk food advertising and companies such as KFC. In that context, corporate responsibility is important, but do the Government need to look at banning such advertising, as they did with tobacco advertising in Formula 1 many years ago?

[Maggie Throup]

As ever, my hon. Friend makes a good point. Everybody has responsibility: the Government have responsibility for their legislation and how it is implemented, and there is corporate responsibility.

Finally, perhaps we will start to see organic change from within the industry itself, rather than needing the Minister to formally effect change through regulation. That is the most effective way to get the change that we need, as we have seen with the reformulation that is going on already. If the industry gets the message loud and clear, it can do it on its own terms rather than being forced into it.

--- Later in debate ---

[Maggie Throup]

I thank you, Ms Dorries, and all hon. Members who have contributed to the debate, including the Minister for his response.

We have had some informative, passionate and wide-ranging speeches, for which I thank everyone. The House is truly at its best when it speaks with one voice. I know that the Minister will take note of the strength of feeling on this important issue and act accordingly. Childhood obesity is a ticking time bomb of public health. The Minister has acknowledged that it is a challenge and a cost both to the individual and to the NHS.

My hon. Friend the Member for South West Bedfordshire (Andrew Selous) highlighted some working examples of where bold and brave action has taken place. The Amsterdam example is something that we should all be looking at, bringing together not only national Government but local government, industry and local people. That is so important and the issue is definitely not going to go away.

The health of our nation must be put at the top of our agenda. I believe that by taking a simple but tough stance on junk food advertising now, we will start to make real progress on the issue that will pay dividends in the years to come. As chair of the all-party group on obesity and a member of the Health Committee, I will continue to push for every measure possible to tackle the obesity epidemic well into the future.

Question put and agreed to.

Resolved,

That this House has considered the effect of junk food advertising on obesity in children.

NHS Winter Crisis

Maggie Throup Excerpts

Monday 8th January 2018 Commons Chamber

[Mr Dunne]

I am glad that the hon. Lady has referred to the social care Green Paper, because that will be published this year, providing an opportunity for all Members to participate in it. It does not sit within my set of responsibilities, so I will come back to the hon. Lady on exactly who will be leading on it.

[Maggie Throup (Erewash) (Con)]

My constituents can access Derby and Nottingham hospitals. The two trusts have been allocated an extra almost £7 million for winter preparedness. Will the Minister reassure me and my constituents that there will be a full analysis of how that extra money is spent, so that we can learn lessons to make sure that we build on good practices for next year?

Oral Answers to Questions

Maggie Throup Excerpts

Tuesday 19th December 2017 Commons Chamber

[Jackie Doyle-Price]

I am grateful to the hon. Gentleman for raising this with me today, because I hope to reassure the House, and anxious people with loved ones in care with Four Seasons, that there is no immediate threat to continuity of care. I and my officials are keeping a very close eye on the situation, so that, with the Care Quality Commission, we ensure that there is a stable transition and that the commercial issues are dealt with in an appropriate way. That is leading to some very challenging conversations, but I can assure him that I and my officials are on it.

[Maggie Throup (Erewash) (Con)]

Given that health and social care are intrinsically linked, even more so now as sustainability and transformation plans are rolled out, does the Minister agree that now is the time to put health and social care under one roof in a combined department?

[Jackie Doyle-Price]

I have always thought that a silo culture was the enemy of good public policy, which means that integrating policy making across Government will tend to lead to better outcomes. I can assure my hon. Friend that I have regular conversations with the Department for Communities and Local Government and, as we approach the long-term funding pressures, we will be very much working in tandem.

Stroke Services

Maggie Throup Excerpts

Tuesday 5th December 2017 Commons Chamber

[Sir David Amess]

I absolutely join the hon. Lady in celebrating the work of all those charities.

The European Stroke Journal found that improving access to thrombolysis and early supported discharge services alone can contribute to reducing the financial burden of stroke on health and social care services. When the benefits of treatments such as mechanical thrombectomy are included, the costs can be lowered significantly. What measures are the Government taking to address the rising costs associated with strokes in England? I very much hope the Government are considering the widespread use of mechanical thrombectomy, which is a new and effective way of treating some of the most serious strokes caused by a blood clot.

[Maggie Throup (Erewash) (Con)]

I have heard first-hand stories about the impact of mechanical thrombectomy and just how fantastic a treatment it is. It can enable people who might have had lifelong disabilities to lead normal lives. I gather it is being rolled out throughout the NHS through specialised commissioning, but does my hon. Friend agree that the roll-out needs to be speeded up, and that we need more people in place to carry out the treatment so that more individuals can benefit from it?

[Sir David Amess]

Even though money is tight, I absolutely agree with my hon. Friend. I have seen a video of the operation, and it is just extraordinary that a catheter can be inserted into a patient’s artery to access the clot, which is then mechanically removed. The technology is extraordinary.

Mechanical thrombectomy significantly reduces disability rates after strokes. It removes clots that are too big to be broken down by drugs alone. For each six-minute delay in the delivery of mechanical thrombectomy, there is a 1% increase in the proportion of people who become disabled. Royal College of Physicians guidelines for stroke care label it as the best recommended practice. It is an effective procedure with very low complication rates. It is highly cost-effective, too. The Stroke Association has calculated that over a 10-year period, the net monetary benefit of 9,000 eligible patients receiving the treatment would be between £530 million and £975 million.

Mechanical thrombectomy enables more stroke survivors to live independently in their own homes, which is crucial, and then to return to work and take control of their lives again, thereby saving the NHS money. It really is a game-changing treatment that could revolutionise stroke victims’ experiences, yet despite NHS England’s agreeing to fund it, it is delivered for only 0.008% of the 85,122 acute stroke admissions, versus the EU benchmark of 3%, so we are really some way behind.

Let me blow the trumpet for Southend, following on from what my hon. Friend the Member for Rochford and Southend East (James Duddridge) said earlier. Southend has been developing an interventional neuroradiology service alongside a hyper-acute stroke service providing thrombectomy. Our service is led and delivered by an interventional neuroradiologist. It has been developed with the local trust board since 2013, but due to a current recommendation that only interventional neuroradiologists can perform the procedure, she is the only person who can perform thrombectomy at the moment, so the service is provided on a “best endeavours” basis and is not, unfortunately, a regular service. The service is currently available only at Southend and nowhere else in Essex. We need to expand it to provide a 24-hour service. The only other place where it is provided is at St George’s Hospital in London.

Mr Paul Guyler, who is a lead consultant in stroke medicine at Southend University Hospital, tells me that less than 1% of ischaemic stroke patients receive endovascular treatment and that, despite around 9,000 patients being eligible for mechanical thrombectomy, only 400 patients received the treatment last year. He has argued that the barriers to this treatment revolve around skills and education, resources and attitudes.

This is not a criticism of my hon. Friend the Minister, because he cannot wave a magic wand and solve all these problems, but Mr Guyler has advised me that there are not enough trained specialists to be able to provide a 24/7 service in all areas. Unfortunately, we also have a postcode lottery, with not enough neuro- radiologists and only 80 interventional neuroradiology operators in the United Kingdom.

[Maggie Throup]

My hon. Friend is being very generous with his time. He has hit the nail on the head: the treatment is very specialist and is carried out by surgeons and neurologists who are not normally there to treat stroke victims. The change in the way in which stroke centres work has been fantastic. Stroke services have been centralised, but we need to go a step further and to make sure that we get the right training for these neurologists so that we can continue to save lives.

[Sir David Amess]

My hon. Friend is spot on in her analysis. I know that the Minister will take the points that she has made to heart and consider how we can improve the present situation.

Consensus forecasts predict that 150 trained people are required to run a fully functioning 24/7 national service. Mr Guyler says that training in stroke intervention is not readily available, that not enough hospitals can afford 24/7 availability and that there are not enough expert neuroradiologists to interpret CT scans. He says that there are turf wars between neurologists, cardiologists, neurosurgeons, radiologists, vascular surgeons and neuro- radiologists on who can and will perform interventional stroke treatment in the future. I do not think it is for politicians to get involved in those turf wars. The medical staff need to sort out between themselves who will lead in these matters. Apparently, there are also turf wars between university and district general hospitals on who should perform the procedure.

Mr Guyler also highlighted the fact that we have the expertise to develop this treatment significantly. The UK has one of only five training simulators in Europe—we should be proud of that—which is based at Anglia Ruskin University.

What are the Government doing to encourage more areas to reconfigure acute stroke services? We do need a new national stroke plan. I was at the launch of the original plan at St James’s Palace many years ago, but it is now time for a new one.

--- Later in debate ---

[Steve Brine]

I echo the hon. Gentleman’s sentiment that that work is critical. I mentioned the Act FAST campaign, which was a heavily evidenced public health campaign showing that the quicker we act after the event, the better the outcome, so he is absolutely right to highlight that issue. However, I am conscious of time, so I am going to press on.

My hon. Friend rightly spoke about mechanical thrombectomy, which he called a game-changer, and he is absolutely right. To continue and build on our stroke service success and to address the costs associated with stroke in England, which was one of my hon. Friend’s first asks, it is imperative that we keep identifying and developing innovative treatments and cutting-edge procedures.

In mechanical thrombectomy, or MT as we shall know it, we have an innovation that we believe can significantly improve patient outcomes, and my hon. Friend spoke about that. In April this year, NHS England announced that it will commission mechanical thrombectomy so that it can become more widely available for patients who have certain types of acute ischaemic stroke, which is a severe form of the condition. My understanding is that work by NHS England is now under way to assess the readiness of 24 neuroscience centres across the country. It is expected that the treatment will start to be phased in later this year and early next year, with an estimated 1,000 patients set to benefit across the first year of introduction. Overall, this will benefit an estimated 8,000 stroke patients a year and save millions of pounds in long-term health and social care costs—my hon. Friend was absolutely right to point out the rising costs to NHS England around this condition.

As the clinical director for stroke at NHS England has said, we are committed to fast-tracking new and effective treatments that will deliver long-term benefits for patients. For me, this treatment is just one example of many that we believe have the potential to tangibly improve patient care and to address rising costs.

[Maggie Throup]

Will my hon. Friend give way?

[Steve Brine]

I am going to press on, because we have to finish at a certain time, but I thank my hon. Friend for her contribution earlier.

Stroke services are an important part of the range of vital services delivered in the part of Essex represented by my hon. Friend the Member for Southend West. It is important that his constituents have the right access to the right care at the right time, which in this case means specialist acute and hyper-acute stroke units. As he knows, and as we have discussed in Adjournment debates previously, there is a lively debate in his local area about the best way to configure services in order to meet these needs. As ever, he makes a powerful case for Southend, which he says has shown itself to be both safe and effective, and I have no reason to doubt his word.

My hon. Friend’s second big question was about what we are doing to transform services. Sustainability and transformation partnerships are absolutely key in this regard. STPs cannot but help in improving stroke services; they have a huge part to play. STPs should bring the local population, NHS organisations and local authority bodies together to propose how they, at a locally designed level, can improve the way that their local health and care is planned and delivered. These local areas have been encouraged to take a collective view of the local health system so that they can explore how best services within the local area, including stroke services, can be streamlined and centred around the patient, and determine what configurations are necessary within each local area to deliver the best possible care. My hon. Friend’s description of turf wars does not surprise me, although it does disappoint me. If he wishes to raise anything specific with me, I ask him to write to me about it. As the Minister responsible for STPs, I do not want to see this happening, and if I can help with it, I will certainly do so.

Much guidance has been issued to the system from us at the centre to help support STPs in making these crucial local reconfiguration decisions. My hon. Friend’s associated STP, Mid and South Essex, is making good progress and has recently been rated through our STP dashboard as being in the top half, so it is a top-half-of-the-table team among STPs. Mid and South Essex’s stroke services compare very well with the best, in many ways, but, as he says, we could be doing much better. One area that it has identified for improvement is that none of the three existing hospitals currently has the right number of specialists to provide the level of specialist stroke unit care that is being proposed. That goes to the heart of some of the examples that he gave from the consultant he has been speaking to.

I welcome the fact that organisations within my hon. Friend’s area, and other STP areas across England, are working in partnership to develop proposals that can really benefit those who matter most—the patients. There are proposals currently out for consultation in his area, which obviously my hon. Friend the Member for Rochford and Southend East (James Duddridge) takes a very close interest in as well. I look forward to seeing the results of that consultation in due course. Knowing my hon. Friends, I feel almost certain that we will be back here discussing that at some point.

I mentioned the tangible progress that has been made in improving both the quality and delivery of stroke services, with evidence-based public health campaigns and really strong, well-organised local services, but there is so much more to do. Patient mortality has indeed fallen, compliance with the standards has risen, and patient experience and satisfaction continues to improve. This is a pathway on which I expect us to continue. New services that my hon. Friend is absolutely right to raise, such as mechanical thrombectomy, can really help us in achieving this. He said what a fascinating piece of medical technology that is. Putting the mesh into the groin for it then to travel through to have such an impact is truly incredible. We are very clever, in many ways.

How this is being delivered is changing, and that is important. The STPs are providing a new way of working. They can be controversial because they involve difficult decisions around reconfiguration, but they should involve local organisations, local services, local people, and local MPs. Local MPs who are not involved in their STPs should ask themselves why not. STPs, and the whole reconfiguration process, are a huge opportunity for us. Locally led commissioning enables local need to be taken into account in decision making about the shape of all services. It can result in very strong local services that can meet these needs, and nowhere is that more important than in stroke care. It is a system that drives improvement in all patient care, and that is what we are about. I thank my hon. Friend for bringing this debate to the House, and other hon. Members who have contributed.

Question put and agreed to.